The pharmacy briefing

News & insight.

Canadian pharmacy and therapeutics news: recalls, shortages, guideline updates and developments in practice.

5 results
Drug Shortages

Hospital Pharmacy Collaboration Preserves Canadian Access to Pediatric Ciprofloxacin Suspension

Mohawk Medbuy reports that hospital pharmacy advocacy helped reverse a planned discontinuation of Canada’s only commercially available ciprofloxacin oral suspension. Continued access may reduce reliance on compounded alternatives or intravenous therapy for children who cannot swallow tablets.

Sep 22, 2026 · 2 min read Read briefing
Photo: Towfiqu barbhuiya/Pexels — illustrative liquid-medication bottles, not the affected CIPRO product. Source: Image source · Pexels licence: Image source
Drug Shortages

Health Canada Designates Dacarbazine for Injection a Tier 3 Critical Shortage

Health Canada has added dacarbazine for injection, used in curative-intent regimens for Hodgkin lymphoma and metastatic melanoma, to its Tier 3 list of the most critical drug shortages -- a designation hospital oncology pharmacy teams should act on now.

Sep 19, 2026 · 2 min read Read briefing
Linda Bartlett / National Cancer Institute, via Wikimedia Commons (public domain) -- illustrative photo of a chemotherapy IV; not the affected product.
Drug Shortages

Dr. Reddy's Semaglutide Shortage Drags On as Generic Ozempic Struggles to Reach Pharmacies

Updated Sep 22, 2026: Health Canada now confirms Dr. Reddy's semaglutide shortage as actual (not just anticipated) and has newly listed Apotex's Apo-Semaglutide as an actual shortage too, driven by demand overflow -- meaning both approved Canadian generics are now officially short, while brand-name Ozempic remains stable.

Sep 13, 2026 · 7 min read Read briefing
Illustrative photo: an Ozempic (semaglutide) injection pen sold in China; Canadian packaging differs. Photo: HualinXMN, CC BY-SA 4.0, via Wikimedia Commons (commons.wikimedia.org/wiki/File:Ozempic®_3ml.jpg)
Drug Shortages

Health Canada Authorizes UK and US Imports of Injectable Cyclophosphamide Amid Tier 3 Shortage

Health Canada has authorized the exceptional importation of UK- and US-labelled cyclophosphamide for injection to relieve a Tier 3 shortage of this essential chemotherapy drug, first declared in February 2026. Hospital and oncology pharmacists need to know the differences between the Canadian, UK, and US-labelled products before dispensing or preparing doses.

Apr 10, 2026 · 3 min read Read briefing
Illustrative chemotherapy vials; not the imported products. National Cancer Institute / Unsplash. Image source

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.